Skip to content

INTEGRATED BIOPHARMA INC: filings

Every INTEGRATED BIOPHARMA INC annual and quarterly report in the SEC record with the published financial measures it tagged, 59 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-05-08fiscal Q3 2026431230001437749-26-015899
10-Q2026-02-11fiscal Q2 2026421180001437749-26-003803
10-Q2025-11-10fiscal Q1 202640820001437749-25-034076
10-K2025-09-23fiscal FY 202543870001437749-25-029711
10-Q2025-05-14fiscal Q3 2025411200001437749-25-016802
10-Q2025-02-13fiscal Q2 2025431190001437749-25-003744
10-Q2024-11-13fiscal Q1 202541840001437749-24-034953
10-K2024-09-20fiscal FY 202443870001437749-24-029768
10-Q2024-05-10fiscal Q3 2024431240001437749-24-016015
10-Q2024-02-12fiscal Q2 2024401100001437749-24-003756
10-Q2023-11-09fiscal Q1 202440820001437749-23-031168
10-K2023-09-15fiscal FY 202343870001437749-23-026022
10-Q2023-05-11fiscal Q3 2023431240001437749-23-013885
10-Q2023-02-10fiscal Q2 2023431200001437749-23-003051
10-Q2022-11-10fiscal Q1 202343880001437749-22-026976
10-K2022-09-13fiscal FY 202243870001437749-22-022334
10-Q2022-05-12fiscal Q3 2022431240001437749-22-012079
10-Q2022-02-10fiscal Q2 2022431200001437749-22-002980
10-Q2021-11-10fiscal Q1 202144920001437749-21-026177
10-K2021-09-02fiscal FY 202143860001437749-21-021375
10-Q2021-05-13fiscal Q3 2021421190001437749-21-011992
10-Q2021-02-12fiscal Q2 2021401120001437749-21-002781
10-Q2020-11-12fiscal Q1 202142860001437749-20-023629
10-K2020-09-23fiscal FY 202042850001437749-20-020123
10-Q2020-05-13fiscal Q3 2020421200001437749-20-010595
10-Q2020-02-12fiscal Q2 2020421170001437749-20-002475
10-Q2019-11-13fiscal Q1 202042870001437749-19-022660
10-K2019-08-29fiscal FY 201942850001437749-19-017611
10-Q2019-05-15fiscal Q3 2019411190001437749-19-010014
10-Q2019-02-13fiscal Q2 2019421090001437749-19-002460
10-Q2018-11-09fiscal Q1 201942830001437749-18-020336
10-K2018-09-12fiscal FY 201841840001437749-18-016922
10-Q2018-05-09fiscal Q3 2018401170001437749-18-009219
10-Q2018-02-09fiscal Q2 2018391060001437749-18-002159
10-Q2017-11-09fiscal Q1 201839790001437749-17-018907
10-K2017-09-01fiscal FY 201736730001437749-17-015520
10-Q2017-05-10fiscal Q3 201735980001437749-17-008597
10-Q2017-02-10fiscal Q2 201735980001437749-17-002119
10-Q2016-11-10fiscal Q1 201737760001437749-16-041746
10-K2016-09-02fiscal FY 201640820001437749-16-038298
10-Q2016-05-13fiscal Q3 2016391070001016504-16-000022
10-Q2016-02-19fiscal Q2 2016391070001016504-16-000020
10-Q2015-11-05fiscal Q1 201639800001016504-15-000014
10-K2015-09-04fiscal FY 201539790001016504-15-000010
10-Q2015-05-14fiscal Q3 2015371020001016504-15-000006
10-Q2015-02-17fiscal Q2 2015381060001016504-15-000004
10-Q2014-11-07fiscal Q1 201538780001016504-14-000013
10-K2014-09-08fiscal FY 201439800001016504-14-000008
10-Q2014-05-14fiscal Q3 2014381070001016504-14-000006
10-Q/A2014-02-13fiscal Q2 2014381080001016504-14-000004
10-Q2013-11-14fiscal Q1 201438820001016504-13-000017
10-K2013-09-30fiscal FY 201344890001016504-13-000011
10-Q2013-05-15fiscal Q3 201335960001016504-13-000006
10-Q2013-02-19fiscal Q2 2013371020001016504-13-000004
10-Q2012-11-19fiscal Q1 201334690001016504-12-000030
10-K2012-10-15fiscal FY 201239790001016504-12-000022
10-Q2012-05-21fiscal Q3 201230810001016504-12-000015
10-Q2012-02-21fiscal Q2 201230820001016504-12-000011
10-Q2011-11-21fiscal Q1 201228560001016504-11-000017

Inspect the source

Entity
INTEGRATED BIOPHARMA INC / CIK 0001016504
Captured
2026-09-20T05:13:02.120Z
SEC response SHA-256
f9ec590a908b38ef1a59595c204a1a8d2ad866020a5c8107d7a41fc708faf496

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001016504.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))